HBXIP, a type of oncoprotein associated with the aggressiveness of breast cancer, upregulates METTL3 by suppressing miRNA let-7g, and then METTL3 promotes the expression of HBXIP in an m6A-dependent manner83. The gene discussed is LAMTOR5; the disease is breast cancer.